PARIS (Reuters) – The French government is seeking job guarantees from drugmaker Sanofi regarding its Doliprane production sites in the event of a sale of its consumer health branch, Economy Minister Antoine Armand said on Monday.
On Friday, Sanofi said it had entered talks to sell a controlling 50% stake in its Opella business – whose brands include Doliprane – to U.S. private equity firm Clayton Dubilier & Rice, but unions fear job cuts due to this.
“As for the the question about jobs, development centres and production centres in Lisieux and Compiegne – if I may also say so, the answer is that these jobs are guaranteed,” added Armand.
(Reporting by Tassilo Hummel and Leigh Thomas; Editing by Sudip Kar-Gupta)
Comments